← Back
Data updated: Mar 29, 2026
DIZAL JIANGSU
Oncology
Pharma
DIZAL JIANGSU is a pharmaceutical company focused on Oncology. Key products include ZEGFROVY.
2025
Since
1
Drugs
-
Trials
1
Approved (2yr)
Key Drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
0 drugs Phase 3: 2 Phase 2: 1 Phase 1: 2
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2025-07-02
- Latest
- 2025-07-02
- Applications
- 1